Storebrand Asset Management’s Axalta AXTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-7,371
Closed -$267K 833
2024
Q3
$267K Hold
7,371
﹤0.01% 752
2024
Q2
$252K Hold
7,371
﹤0.01% 753
2024
Q1
$253K Sell
7,371
-14,696
-67% -$480K ﹤0.01% 773
2023
Q4
$750K Sell
22,067
-11,131
-34% -$333K ﹤0.01% 708
2023
Q3
$893K Hold
33,198
﹤0.01% 681
2023
Q2
$1.09M Sell
33,198
-1,470
-4% -$45.6K 0.01% 674
2023
Q1
$1.05M Sell
34,668
-2,293
-6% -$65.9K 0.01% 674
2022
Q4
$941K Hold
36,961
0.01% 675
2022
Q3
$778K Sell
36,961
-408
-1% -$10K ﹤0.01% 682
2022
Q2
$826K Sell
37,369
-33,683
-47% -$856K ﹤0.01% 691
2022
Q1
$1.75M Sell
71,052
-52,248
-42% -$1.46M 0.01% 638
2021
Q4
$4.08M Hold
123,300
0.02% 539
2021
Q3
$3.6M Sell
123,300
-1,233
-1% -$36.9K 0.02% 571
2021
Q2
$3.8M Sell
124,533
-3,703
-3% -$117K 0.02% 578
2021
Q1
$3.79M Hold
128,236
0.02% 567
2020
Q4
$3.66M Buy
128,236
+5,665
+5% +$154K 0.02% 549
2020
Q3
$2.72M Hold
122,571
0.02% 564
2020
Q2
$2.76M Hold
122,571
0.02% 527
2020
Q1
$2.12M Buy
+122,571
New +$3.14M 0.02% 516

Other funds holding AXTA

Storebrand Asset Management's AXTA Position: Q4 2024 in Review

Storebrand Asset Management sold out of Axalta (AXTA) in Q4 2024, closing a stake of 7,371 shares — an estimated $267K sold.

Storebrand Asset Management first reported a position in AXTA in Q1 2020 and held it in 19 quarters. The position peaked at $4.08M in Q4 2021. 399 funds tracked by Wall St. Rank hold AXTA as of Q4 2024.

  • Storebrand Asset Management reported no remaining Axalta position as of Q4 2024 after selling out during the quarter.
  • Storebrand Asset Management sold 7,371 Axalta shares in Q4 2024, an estimated $267K.
  • Storebrand Asset Management first reported a position in Axalta in Q1 2020 and held it in 19 quarters.
  • Storebrand Asset Management's Axalta position peaked at $4.08M in Q4 2021.
  • 399 funds tracked by Wall St. Rank held Axalta as of Q4 2024.

Based on Storebrand Asset Management's 13F filing for Q4 2024, filed 17 Jun 2026.